or Try an Advanced Search...

    Technical Analysis for ADCT - ADC Therapeutics SA

    Grade Last Price % Change Price Change
    F 1.99 0.25% 0.01
    ADCT closed down 3.88 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ADCT trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.25%
    Lower Bollinger Band Walk Weakness 0.25%
    Inside Day Range Contraction 0.25%
    Wide Bands Range Expansion 0.25%
    Below Lower BB Weakness 0.25%
    Down 3 Days in a Row Weakness 0.25%
    Down 4 Days in a Row Weakness 0.25%
    Down 5 Days in a Row Weakness 0.25%
    Lower Bollinger Band Touch Weakness 0.25%
    Oversold Stochastic Weakness 0.25%
    Older End-of-Day Signals for ADCT ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 4 hours ago
    Down 1% about 4 hours ago
    Up 1% about 4 hours ago
    Rose Above Lower Bollinger Band about 4 hours ago
    Down 5% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ADCT Chart by TradingView
    Basic chart:

    Profile

    ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix

    Is ADCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ...
    Nov 9 ADC Therapeutics SA (ADCT) Q3 2024 Earnings Call Transcript
    Nov 9 ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations
    Nov 8 ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
    Nov 7 ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
    Nov 7 ADC Therapeutics Non-GAAP EPS of -$0.28, revenue of $18.46M misses by $0.04M
    Nov 7 ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update
    Nov 6 Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates
    Nov 5 ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting
    Nov 4 ADC Therapeutics to Present at November Investor Conferences
    See more ADCT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.04
    52 Week Low 0.6883
    Average Volume 382,790
    200-Day Moving Average 3.62
    50-Day Moving Average 2.97
    20-Day Moving Average 2.79
    10-Day Moving Average 2.58
    Average True Range 0.23
    RSI (14) 24.24
    ADX 17.2
    +DI 13.15
    -DI 37.13
    Chandelier Exit (Long, 3 ATRs) 2.62
    Chandelier Exit (Short, 3 ATRs) 2.56
    Upper Bollinger Bands 3.48
    Lower Bollinger Band 2.10
    Percent B (%b) -0.08
    BandWidth 49.58
    MACD Line -0.22
    MACD Signal Line -0.11
    MACD Histogram -0.1094
    Fundamentals Value
    Market Cap 159.67 Million
    Num Shares 80.6 Million
    EPS -2.18
    Price-to-Earnings (P/E) Ratio -0.91
    Price-to-Sales 2.87
    Price-to-Book 2.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.21
    Resistance 3 (R3) 2.23 2.17 2.17
    Resistance 2 (R2) 2.17 2.11 2.16 2.16
    Resistance 1 (R1) 2.07 2.07 2.04 2.06 2.15
    Pivot Point 2.01 2.01 2.00 2.00 2.01
    Support 1 (S1) 1.92 1.95 1.89 1.90 1.81
    Support 2 (S2) 1.86 1.92 1.85 1.80
    Support 3 (S3) 1.76 1.86 1.79
    Support 4 (S4) 1.75